Navigation Links
Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference

BOTHELL, Wash., Feb. 17 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, today announced today that it will present at the Roth 21st Annual OC Growth Stock Conference at the Ritz Carlton Laguna Nigel. John Hinson, president and chief executive officer, will review the Company's business strategy and recent financial results during the Company's presentation on Wednesday, February 18 at 11:30 a.m. local time.


Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company's website at An archived replay of the presentation will also be available following the live presentation and can be accessed at

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit

Forward Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's expectations regarding revenues for the fourth quarter and full year 2008, charges relating to the restructuring announced in this press release, and expectations regarding the impact of the restructuring on 2009 operating results. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in Cardiac Science Corporation's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2008. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

    For more information,
    Company Contact:                Investor Contact:    Media Contact:
    Mike Matysik                    Doug Sherk           Christopher Gale
    Cardiac Science Corporation     Jenifer Kirtland     EVC Group Inc.
    Senior Vice President and CFO   EVC Group Inc.       646.201.5431
    425.402.2009                    415.896.6820         203.570.4681


SOURCE Cardiac Science
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sudden Cardiac Death Rare in Young Athletes
2. Global Economic Meltdown - Is the European Cardiac Rhythm Management Market Spared?
3. TV News Coverage Reports on InnerCools CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago
4. Worlds First Cardiac Adult Stem Cell Trial to Take Place in Louisville
5. iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies
6. Cardiac Science Increases R&D Capacity With 3-year Syncroness Agreement
7. The Sudden Cardiac Arrest Association Shoots Straight for the Heart
8. Experts Urge Limits on Use of Cardiac CT Scans
9. Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
10. Easing regulations does not mean lower quality of cardiac care
11. New stretchable electrodes created to study stresses on cardiac cells
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog Distortion ... tool designed specially for Final Cut Pro X. FCPX users can ... easy-to-use modification controls. Destoying and creating chaotic distortion is now quick and simple, ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Safe storage for ... of two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, ... patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often than ...
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed ... As people age, more care is needed, especially with Alzheimer’s, dementia and other ... are being overworked. The forgotten part of this equation: 80 percent of medical ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... , Nov. 29, 2015 CIVCO Medical ... technology at the Radiological Society of ... Chicago November 29 – December ... designed to offer customers unrivaled versatility, enhanced user ... --> ...
(Date:11/27/2015)... -- --> --> ... potential to save costs, improve treatment quality and accelerate ... exploited as yet. Here, particular emphasis is placed on ... tablet or directly at the patients, bedside. ... -->      (Photo: ) ...
(Date:11/27/2015)... 2015 Research and Markets ( ) ... Devices Market 2015-2019" report to their offering. ... this report, the author the present scenario and growth ... To calculate the market size, the report considers revenue ... Hormonal IUDs and copper IUDs. The report forecasts the ...
Breaking Medicine Technology: